Ozari vs Hone Health: Which GLP-1 Telehealth Provider Is Right for You?

Sarah spent three weeks researching telehealth GLP-1 providers before she finally sat down to compare her top two choices: Ozari Health and Hone Health. Both offered virtual consultations, both could prescribe the medications she'd been reading about, and both seemed legitimate. But the differences in pricing, medication formulations, and approach to care made her realize these weren't interchangeable options. Like Sarah, you're probably weighing your choices carefully, and the details matter when you're committing to a treatment that could last months or years.

The telehealth GLP-1 space has exploded over the past two years, with dozens of companies promising convenient access to weight loss medications. Some focus exclusively on women's health, others target men's wellness, and a few try to serve everyone. Ozari Health and Hone Health represent two different approaches in this landscape. Understanding how they differ—from the medications they offer to who they're designed to serve—can save you time, money, and frustration down the road.

Pricing Structure and What You Actually Pay

Let's start with the number that matters most to many people: monthly cost. Ozari Health offers compounded semaglutide and tirzepatide starting at $99 per month, with pricing that remains consistent as you move through different dosage levels. There's no membership fee, no hidden consultation charges, and the medication ships directly to your door with shipping included in that monthly price.

Hone Health takes a different approach. They're primarily known as a men's hormone optimization clinic that has expanded into GLP-1 medications. Their pricing structure includes a membership component along with medication costs. You'll pay around $199 per month for compounded semaglutide, though this can vary based on dosage and whether you're bundling other treatments. For patients interested in testosterone therapy or other hormone treatments alongside GLP-1s, Hone's model might offer convenience. But if you're specifically seeking weight management medication, you're paying more for services you may not need.

The cost difference adds up quickly. Over six months—a typical timeframe to see significant results from GLP-1 therapy—you'd spend approximately $594 with Ozari versus $1,194 or more with Hone. That's a $600 difference for essentially the same active medication. Both companies offer compounded versions of FDA-approved drugs, which is why they can price below brand-name Wegovy or Zepbound. The compounding pharmacy model allows for flexibility in dosing and significant cost savings, but the markup between providers can be substantial.

Payment flexibility matters too. Ozari accepts HSA and FSA cards, making it easier to use pre-tax dollars for your treatment. They also don't require long-term contracts, so you're not locked into a subscription if your needs change or you decide the medication isn't right for you. We see this flexibility reduce anxiety for patients who are hesitant to commit to a new treatment protocol. Nobody wants to feel trapped in a service that isn't working for them.

One important note about pricing: both companies may adjust costs as you increase dosage throughout your treatment journey. However, Ozari maintains transparent pricing tiers on their website, while Hone's pricing can be less straightforward, often requiring a consultation before you get a clear picture of total monthly costs. When you're budgeting for ongoing treatment, that transparency makes planning much easier.

Medication Options and Formulations

The medications themselves are where things get interesting. Ozari Health specializes exclusively in GLP-1 receptor agonists for metabolic health and weight management. They offer both compounded semaglutide (the same active ingredient as Wegovy and Ozempic) and compounded tirzepatide (the same active ingredient as Zepbound and Mounjaro). This dual-agonist option is significant because tirzepatide works on both GLP-1 and GIP receptors, which led to an average weight loss of 20.9% of body weight in the SURMOUNT-1 trial compared to 14.9% with semaglutide in the STEP 1 trial.

Having access to both medications through one provider gives you flexibility. If you start with semaglutide and hit a plateau or experience side effects, switching to tirzepatide becomes a simple conversation with your provider rather than a search for a new telehealth company. Some patients respond better to one formulation than the other, and we can't always predict who will do best with which medication until we try it.

Hone Health's medication offerings are a bit more scattered. While they do provide compounded semaglutide, their primary focus remains on testosterone therapy, supplements, and men's sexual health treatments. GLP-1 medications seem to be a newer addition to their roster rather than their core competency. They don't currently offer tirzepatide in most markets, which limits your options if semaglutide doesn't work well for you. For a patient specifically seeking weight management through GLP-1 therapy, working with a specialist provider often yields better results than a generalist approach.

The compounding pharmacy partnerships also differ. Ozari works with 503B FDA-registered outsourcing facilities, which operate under stricter regulations than standard compounding pharmacies. These facilities must follow current Good Manufacturing Practices (cGMP), undergo regular FDA inspections, and can ship across state lines more freely. Hone uses a network of compounding pharmacies that may vary by region, which can lead to inconsistencies in medication quality and availability depending on where you live.

Injection delivery systems are another practical consideration. Both companies provide subcutaneous injections that you'll self-administer weekly. Ozari includes all necessary supplies—needles, syringes, alcohol wipes, and sharps disposal container—with your first shipment and as needed thereafter. The injection process is straightforward, but having everything arrive together reduces the stress of starting treatment. Some patients report that Hone requires them to source certain supplies separately, though this may vary by region.

The Patient Experience: Consultations and Ongoing Care

Your relationship with your prescribing provider shapes your entire treatment experience. Ozari's model centers on asynchronous telehealth, which means you'll complete a detailed medical intake form that a licensed physician reviews. If you're a good candidate for GLP-1 therapy, they'll approve your prescription without requiring a scheduled video call. This approach works well for busy people who don't want to coordinate schedules for a video appointment. You'll have access to your care team through messaging for questions, concerns about side effects, or dosage adjustments.

For some patients, this level of interaction feels sufficient. You're not dealing with complex medical questions that require face-to-face discussion—you're managing a relatively straightforward medication protocol with well-established titration schedules. Quick message-based support often resolves issues faster than waiting for a scheduled appointment slot. That said, if you're someone who values regular video check-ins or prefers more hands-on provider interaction, this model might feel too hands-off.

Hone Health emphasizes their synchronous telemedicine appointments, meaning you'll have scheduled video calls with providers. For their broader men's health focus—managing testosterone levels, addressing sexual dysfunction, optimizing multiple hormones simultaneously—this makes sense. These are complex interventions that benefit from real-time conversation. But for straightforward GLP-1 therapy, many patients find that scheduled appointments become an inconvenience rather than a benefit, especially once you're established on a stable dose.

Response times for questions and concerns differ between the two platforms. Ozari's care team typically responds to patient messages within 24 hours on weekdays, with support specifically trained in GLP-1 therapy and common side effects like nausea, constipation, and injection site reactions. Because their entire focus is on these medications, the support staff knows the common questions before you ask them. Hone's response times can be longer, particularly if your question falls outside their core hormone therapy expertise.

The onboarding process sets expectations for your entire treatment journey. Ozari provides educational materials specifically about GLP-1 therapy—what to expect in the first month, how to manage side effects, when to increase your dose, what dietary changes support better results. These resources are tailored to the medication you're taking. Hone's educational content tends to be broader, covering their full range of services, which means you might need to search for GLP-1-specific guidance or ask more questions that a specialized provider would have addressed proactively.

Who Each Provider Actually Serves Best

Here's where we need to be honest about positioning. Hone Health was built for men, specifically men interested in hormone optimization as they age. Their branding, marketing, and core services reflect this focus. They've expanded into GLP-1 medications because there's demand and overlap—some men pursuing testosterone therapy also want weight management support. If you're a man already receiving testosterone treatment through Hone and want to add a GLP-1, staying with one provider creates convenience.

But if your primary goal is weight management or metabolic health improvement through GLP-1 therapy, Hone isn't necessarily your best choice simply because you're male. GLP-1 medications work the same way regardless of gender. The STEP trials included both men and women, as did the SURMOUNT trials. While men and women may experience slightly different rates of weight loss and side effect profiles, these differences don't require gender-specific prescribing approaches for GLP-1s alone.

Ozari Health serves all adults who are candidates for GLP-1 therapy, regardless of gender. Their focus on metabolic health and weight management means the entire experience is optimized for patients seeking these specific outcomes. You're not navigating a platform designed for a different primary purpose, and you're not paying for infrastructure built around services you don't need. The educational content, support resources, and provider expertise all align with your goals.

Geographic availability can also influence your choice. Ozari currently operates in most U.S. states, with a growing footprint as they navigate individual state telemedicine and pharmacy regulations. Hone's availability varies more significantly by state, particularly for their compounded medications. It's worth verifying that your preferred provider actually serves your location before you invest time in the intake process.

From the Ozari Care Team

We recommend starting with a clear picture of what you actually need from a GLP-1 provider before getting distracted by additional services you might not use. In our experience, patients do best when their provider specializes in the specific treatment they're seeking—you want a care team that's seen hundreds of patients through GLP-1 therapy, knows the nuances of dosing adjustments, and can troubleshoot side effects quickly. What we tell our patients is that the best provider isn't necessarily the one with the most services, but the one that excels at the specific thing you need right now.

Key Takeaways

• Ozari's pricing starts at $99/month with no membership fees, compared to Hone's $199/month or higher with membership components—a potential savings of $600 or more over six months of treatment
• Ozari offers both compounded semaglutide and tirzepatide, giving you flexibility to switch if one medication doesn't work well, while Hone focuses primarily on semaglutide alongside their broader men's health services
• Hone Health's platform is designed primarily for men seeking hormone optimization, while Ozari specializes exclusively in GLP-1 therapy for metabolic health and weight management for all adults
• Both providers use compounded medications from FDA-registered pharmacies, but Ozari's partnerships with 503B outsourcing facilities offer more consistent quality standards and broader shipping availability
• Your choice should ultimately depend on whether you want a specialized GLP-1 provider or a broader men's wellness platform that includes GLP-1 as one of many services

Frequently Asked Questions

Is compounded semaglutide from Ozari or Hone as effective as brand-name Wegovy?

Compounded semaglutide contains the same active ingredient as Wegovy—it's the identical molecule that produces the same effects in your body. The main differences are in the formulation process and FDA approval status. Brand-name medications go through extensive clinical trials and FDA approval processes, while compounded versions are made by specialized pharmacies following established formulas. In our clinical experience, patients achieve comparable results with compounded semaglutide when dosed appropriately and when the compounding pharmacy follows strict quality standards, which both Ozari and Hone's pharmacy partners do.

Can I switch from Hone to Ozari if I'm already on a GLP-1 medication?

Yes, switching between telehealth providers is straightforward as long as you maintain continuity in your dosing. You'll want to know your current dose and how long you've been taking it, then provide that information during Ozari's intake process. The prescribing physician can continue you at your current dose or make adjustments based on your progress and any side effects you're experiencing. Most patients switch providers without any gap in treatment as long as they time their new prescription to arrive before their current supply runs out.

Does insurance cover GLP-1 medications from either Ozari or Hone?

Most traditional insurance plans don't cover compounded GLP-1 medications, which is actually why compounded versions exist—they provide an affordable alternative to brand-name medications that cost $1,000+ per month without insurance. However, both Ozari and Hone accept HSA and FSA cards, allowing you to use pre-tax healthcare dollars for your treatment. Some patients find that even paying out-of-pocket for compounded medication costs less than their insurance copay would be for brand-name versions, especially if their plan requires prior authorization or has high deductibles.

What happens if I experience side effects with either provider?

Both Ozari and Hone provide access to their care teams for managing side effects, though the response format differs. With Ozari, you'd message your care team describing your symptoms, and they'd typically respond within 24 hours with recommendations for managing nausea, adjusting injection timing, modifying your diet, or potentially adjusting your dose. Hone offers similar support through their patient portal and scheduled follow-ups. The most common side effects—nausea, constipation, and decreased appetite—usually improve within a few weeks as your body adjusts, and both providers can help you navigate this adjustment period.

How do I know if I'm actually a good candidate for GLP-1 therapy?

Generally, you're a good candidate if you have a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition like high blood pressure, type 2 diabetes, or high cholesterol. Both Ozari and Hone will screen for contraindications during their intake process, including personal or family history of thyroid cancer, history of pancreatitis, or other medical conditions that make GLP-1 therapy inappropriate. You're not a good candidate if you're pregnant, planning to become pregnant soon, or have certain rare endocrine disorders. The intake questionnaire for either provider will identify these issues before a physician reviews your case.

At Ozari Health, we offer compounded Semaglutide and Tirzepatide as low as $99/month, shipped to your door. Our platform is designed specifically for patients seeking effective, affordable GLP-1 therapy for weight management and metabolic health. Learn more at ozarihealth.com.